Market Tracker

05/25 8:48am ET

Eli Lilly and Co (NYSE:LLY)

74.99
Delayed Data
As of May 24
 +0.91 / +1.23%
Today’s Change
67.88
Today|||52-Week Range
92.85
-11.00%
Year-to-Date
2 Promising Biopharmas Reach Key Junctures
May 23 / TheStreet.com - Paid Partner Content
Eli Lilly And (LLY) Is Weak On High Volume Today
May 19 / TheStreet.com - Paid Partner Content
Big Hedge Funds Love These 5 Stocks Big -- Do You?
May 23 / TheStreet.com - Paid Partner Content
Agilent's Unit Dako Expands the Use of PD-L1 Test in Europe
May 16 / Zacks.com - Paid Partner Content
Most Bought and Sold Stocks by Hedge Funds
May 22 / GuruFocus News - Paid Partner Content
Biotech groups sink their teeth into the Big Apple
May 16 / FT.com - Paid Partner Content
'Party Drug' Could Be Johnson & Johnson's Entry Into Antidepressant Market
May 22 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close74.08
Today’s open74.55
Day’s range74.36 - 75.20
Volume3,712,042
Average volume (3 months)4,825,087
Market cap$82.8B
Dividend yield2.72%
Data as of 05/24/2016

Growth & Valuation

Earnings growth (last year)+1.35%
Earnings growth (this year)+4.37%
Earnings growth (next 5 years)+14.00%
Revenue growth (last year)+1.75%
P/E ratio34.4
Price/Sales4.50
Price/Book5.69

Competitors

 Today’s
change
Today’s
% change
CELGCelgene+2.68+2.65%
AGNAllergan+3.38+1.50%
AZNAstraZeneca+0.83+2.90%
ABBVAbbVie+1.40+2.36%
Data as of 05/24/2016

Financials

Next reporting dateJuly 26, 2016
EPS forecast (this quarter)$0.85
Annual revenue (last year)$20.0B
Annual profit (last year)$2.4B
Net profit margin12.07%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
John C. Lechleiter
Chief Financial Officer &
EVP-Global Services
Derica W. Rice
Corporate headquarters
Indianapolis, Indiana

Forecasts